Atlas Trials

Zydus Lifesciences Limited

21 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Zydus Lifesciences Limited

RecordFirmDate
A Study to Determine Safety, Tolerability, and Pharmacokinetics of Different Orally Administered Regimens of the Combination ZY19489-Ferroquine in Adult Asymptomatic Plasmodium Falciparum Carriers (NCT05911828)Zydus Lifesciences Limited2024-08-30
A Study to Evaluate the Efficacy and Safety of ZYIL1 Oral Capsules for the Treatment of Patients With Mild to Moderately Active Ulcerative Colitis Resistant or Intolerant to Oral Aminosalicylates (NCT06398808)Zydus Lifesciences Limited2024-04-08
Efficacy, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ZYIL1 in Patients With Amyotrophic Lateral Sclerosis (NCT05981040)Zydus Lifesciences Limited2023-11-09
A Study to Evaluate the Safety and Effectiveness of Saroglitazar 4 mg in Patients With NAFLD With Comorbidities (NCT05872269)Zydus Lifesciences Limited2023-07-20
A Study to Evaluate Safety, Efficacy, Pharmacokinetics, and Immunogenicity of Test Pertuzumab (ZRC-3277, Cadila Healthcare Ltd.,) (NCT05283837)Zydus Lifesciences Limited2022-09-26
A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ZYIL1 in Subjects With Cryopyrin Associated Periodic Syndromes (CAPS) (NCT05186051)Zydus Lifesciences Limited2022-06-01
A Study Of Zy-19489 Administered Via Oral Route To Investigate The Safety, Tolerability And Pharmacokinetics In Healthy Adult Human Subjects (NCT05206201)Zydus Lifesciences Limited2021-08-25
A Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetics and Pharmacodynamics of ZYIL1 Following Oral Administration in Healthy Volunteers (NCT04972188)Zydus Lifesciences Limited2021-07-12
Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetics and Pharmacodynamics of ZYIL1 Following Oral Administration in Healthy Volunteers (NCT04731324)Zydus Lifesciences Limited2020-12-28
Pegylated Interferon - α2b With SARSCoV- 2 (COVID-19) (NCT04480138)Zydus Lifesciences Limited2020-08-11
Desidustat in the Management of COVID-19 Patients (NCT04463602)Zydus Lifesciences Limited2020-07-25
Desidustat in the Treatment of Anemia in CKD on Dialysis Patients (NCT04215120)Zydus Lifesciences Limited2020-01-04
Desidustat in the Treatment of Anemia in CKD (NCT04012957)Zydus Lifesciences Limited2019-07-20

Track Zydus Lifesciences Limited automatically

Every clearance here is in the API, with alerts when new ones post.